188 related articles for article (PubMed ID: 22846908)
1. Construction of a stability landscape of the CH3 domain of human IgG1 by combining directed evolution with high throughput sequencing.
Traxlmayr MW; Hasenhindl C; Hackl M; Stadlmayr G; Rybka JD; Borth N; Grillari J; Rüker F; Obinger C
J Mol Biol; 2012 Oct; 423(3):397-412. PubMed ID: 22846908
[TBL] [Abstract][Full Text] [Related]
2. Stability assessment on a library scale: a rapid method for the evaluation of the commutability and insertion of residues in C-terminal loops of the CH3 domains of IgG1-Fc.
Hasenhindl C; Traxlmayr MW; Wozniak-Knopp G; Jones PC; Stadlmayr G; Rüker F; Obinger C
Protein Eng Des Sel; 2013 Oct; 26(10):675-82. PubMed ID: 24006374
[TBL] [Abstract][Full Text] [Related]
3. IgG2 Fc structure and the dynamic features of the IgG CH2-CH3 interface.
Teplyakov A; Zhao Y; Malia TJ; Obmolova G; Gilliland GL
Mol Immunol; 2013 Nov; 56(1-2):131-9. PubMed ID: 23628091
[TBL] [Abstract][Full Text] [Related]
4. Stabilisation of the Fc fragment of human IgG1 by engineered intradomain disulfide bonds.
Wozniak-Knopp G; Stadlmann J; Rüker F
PLoS One; 2012; 7(1):e30083. PubMed ID: 22272277
[TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics simulation of the crystallizable fragment of IgG1-insights for the design of Fcabs.
Lai B; Hasenhindl C; Obinger C; Oostenbrink C
Int J Mol Sci; 2014 Jan; 15(1):438-55. PubMed ID: 24451126
[TBL] [Abstract][Full Text] [Related]
6. Engineering of Immunoglobulin Fc Heterodimers Using Yeast Surface-Displayed Combinatorial Fc Library Screening.
Choi HJ; Kim YJ; Choi DK; Kim YS
PLoS One; 2015; 10(12):e0145349. PubMed ID: 26675656
[TBL] [Abstract][Full Text] [Related]
7. Directed evolution of Her2/neu-binding IgG1-Fc for improved stability and resistance to aggregation by using yeast surface display.
Traxlmayr MW; Lobner E; Antes B; Kainer M; Wiederkum S; Hasenhindl C; Stadlmayr G; Rüker F; Woisetschläger M; Moulder K; Obinger C
Protein Eng Des Sel; 2013 Apr; 26(4):255-65. PubMed ID: 23267121
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive elucidation of the structural and functional roles of engineered disulfide bonds in antibody Fc fragment.
Zeng F; Yang C; Gao X; Li X; Zhang Z; Gong R
J Biol Chem; 2018 Dec; 293(49):19127-19135. PubMed ID: 30327432
[TBL] [Abstract][Full Text] [Related]
9. Directed evolution of stabilized IgG1-Fc scaffolds by application of strong heat shock to libraries displayed on yeast.
Traxlmayr MW; Faissner M; Stadlmayr G; Hasenhindl C; Antes B; Rüker F; Obinger C
Biochim Biophys Acta; 2012 Apr; 1824(4):542-9. PubMed ID: 22285845
[TBL] [Abstract][Full Text] [Related]
10. Engineered IgG1-Fc--one fragment to bind them all.
Lobner E; Traxlmayr MW; Obinger C; Hasenhindl C
Immunol Rev; 2016 Mar; 270(1):113-31. PubMed ID: 26864108
[TBL] [Abstract][Full Text] [Related]
11. Creating stable stem regions for loop elongation in Fcabs - insights from combining yeast surface display, in silico loop reconstruction and molecular dynamics simulations.
Hasenhindl C; Lai B; Delgado J; Traxlmayr MW; Stadlmayr G; Rüker F; Serrano L; Oostenbrink C; Obinger C
Biochim Biophys Acta; 2014 Sep; 1844(9):1530-40. PubMed ID: 24792385
[TBL] [Abstract][Full Text] [Related]
12. Identifying amino acid residues that influence plasma clearance of murine IgG1 fragments by site-directed mutagenesis.
Kim JK; Tsen MF; Ghetie V; Ward ES
Eur J Immunol; 1994 Mar; 24(3):542-8. PubMed ID: 8125126
[TBL] [Abstract][Full Text] [Related]
13. Weak protein interactions and pH- and temperature-dependent aggregation of human Fc1.
Wu H; Truncali K; Ritchie J; Kroe-Barrett R; Singh S; Robinson AS; Roberts CJ
MAbs; 2015; 7(6):1072-83. PubMed ID: 26267255
[TBL] [Abstract][Full Text] [Related]
14. Designing Fcabs: well-expressed and stable high affinity antigen-binding Fc fragments.
Wozniak-Knopp G; Stadlmayr G; Perthold JW; Stadlbauer K; Woisetschläger M; Sun H; Rüker F
Protein Eng Des Sel; 2017 Sep; 30(9):657-671. PubMed ID: 28981753
[TBL] [Abstract][Full Text] [Related]
15. Hinge-Deficient IgG1 Fc Fusion: Application to Human Lactoferrin.
Shiga Y; Murata D; Sugimoto A; Oshima Y; Tada M; Ishii-Watabe A; Imai K; Tomii K; Takeuchi T; Kagaya S; Sato A
Mol Pharm; 2017 Sep; 14(9):3025-3035. PubMed ID: 28763236
[TBL] [Abstract][Full Text] [Related]
16. Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation.
Liu D; Ren D; Huang H; Dankberg J; Rosenfeld R; Cocco MJ; Li L; Brems DN; Remmele RL
Biochemistry; 2008 May; 47(18):5088-100. PubMed ID: 18407665
[TBL] [Abstract][Full Text] [Related]
17. Evidence that the hinge region plays a role in maintaining serum levels of the murine IgG1 molecule.
Kim JK; Tsen MF; Ghetie V; Ward ES
Mol Immunol; 1995 May; 32(7):467-75. PubMed ID: 7783750
[TBL] [Abstract][Full Text] [Related]
18. A variant human IgG1-Fc mediates improved ADCC.
Stewart R; Thom G; Levens M; Güler-Gane G; Holgate R; Rudd PM; Webster C; Jermutus L; Lund J
Protein Eng Des Sel; 2011 Sep; 24(9):671-8. PubMed ID: 21596686
[TBL] [Abstract][Full Text] [Related]
19. Construction of pH-sensitive Her2-binding IgG1-Fc by directed evolution.
Traxlmayr MW; Lobner E; Hasenhindl C; Stadlmayr G; Oostenbrink C; Rüker F; Obinger C
Biotechnol J; 2014 Aug; 9(8):1013-22. PubMed ID: 24964247
[TBL] [Abstract][Full Text] [Related]
20. Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies.
Ionescu RM; Vlasak J; Price C; Kirchmeier M
J Pharm Sci; 2008 Apr; 97(4):1414-26. PubMed ID: 17721938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
